IRIS Accounts Production v24.2.0.383 10420132 Board of Directors 1.11.22 31.10.23 31.10.23 false true false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104201322022-10-31104201322023-10-31104201322022-11-012023-10-31104201322021-10-31104201322021-11-012022-10-31104201322022-10-3110420132ns15:EnglandWales2022-11-012023-10-3110420132ns14:PoundSterling2022-11-012023-10-3110420132ns10:Director12022-11-012023-10-3110420132ns10:PrivateLimitedCompanyLtd2022-11-012023-10-3110420132ns10:SmallEntities2022-11-012023-10-3110420132ns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3110420132ns10:SmallCompaniesRegimeForDirectorsReport2022-11-012023-10-3110420132ns10:SmallCompaniesRegimeForAccounts2022-11-012023-10-3110420132ns10:AbridgedAccounts2022-11-012023-10-3110420132ns10:OrdinaryShareClass12022-11-012023-10-3110420132ns10:Director22022-11-012023-10-3110420132ns10:RegisteredOffice2022-11-012023-10-3110420132ns5:CurrentFinancialInstruments2023-10-3110420132ns5:CurrentFinancialInstruments2022-10-3110420132ns5:Non-currentFinancialInstruments2023-10-3110420132ns5:Non-currentFinancialInstruments2022-10-3110420132ns5:ShareCapital2023-10-3110420132ns5:ShareCapital2022-10-3110420132ns5:RetainedEarningsAccumulatedLosses2023-10-3110420132ns5:RetainedEarningsAccumulatedLosses2022-10-3110420132ns10:OrdinaryShareClass12023-10-31
REGISTERED NUMBER: 10420132 (England and Wales)















Report of the Directors and


Abridged Financial Statements for the Year Ended 31 October 2023

for

AL Bioservices Ltd

AL Bioservices Ltd (Registered number: 10420132)






Contents of the Financial Statements
for the Year Ended 31 October 2023




Page

Company Information 1

Report of the Directors 2

Abridged Balance Sheet 3

Notes to the Financial Statements 5


AL Bioservices Ltd

Company Information
for the Year Ended 31 October 2023







DIRECTORS: Miss A Leach
Ms N Leach





REGISTERED OFFICE: Office Suite 7, Topley House
52 Wash Lane
Bury
Greater Manchester
BL9 6AS





REGISTERED NUMBER: 10420132 (England and Wales)





ACCOUNTANTS: TH Accounting Solutions
Suite 3
Turner Business Centre
Greengate
Middleton
Greater Manchester
M24 1RU

AL Bioservices Ltd (Registered number: 10420132)

Report of the Directors
for the Year Ended 31 October 2023

The directors present their report with the financial statements of the company for the year ended 31 October 2023.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 November 2022 to the date of this report.

Miss A Leach
Ms N Leach

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Miss A Leach - Director


26 August 2024

AL Bioservices Ltd (Registered number: 10420132)

Abridged Balance Sheet
31 October 2023

31.10.23 31.10.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 14,563 21,157

CURRENT ASSETS
Debtors - 11,708
Cash at bank 16,646 8,748
16,646 20,456
CREDITORS
Amounts falling due within one year 19,647 13,364
NET CURRENT (LIABILITIES)/ASSETS (3,001 ) 7,092
TOTAL ASSETS LESS CURRENT
LIABILITIES

11,562

28,249

CREDITORS
Amounts falling due after more than one
year

13,848

15,984
NET (LIABILITIES)/ASSETS (2,286 ) 12,265

CAPITAL AND RESERVES
Called up share capital 5 1 1
Retained earnings (2,287 ) 12,264
SHAREHOLDERS' FUNDS (2,286 ) 12,265

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

AL Bioservices Ltd (Registered number: 10420132)

Abridged Balance Sheet - continued
31 October 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 October 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 August 2024 and were signed on its behalf by:





Miss A Leach - Director


AL Bioservices Ltd (Registered number: 10420132)

Notes to the Financial Statements
for the Year Ended 31 October 2023

1. STATUTORY INFORMATION

AL Bioservices Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 3 ) .

AL Bioservices Ltd (Registered number: 10420132)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 November 2022 105,435
Disposals (8,000 )
At 31 October 2023 97,435
DEPRECIATION
At 1 November 2022 84,278
Charge for year 3,394
Eliminated on disposal (4,800 )
At 31 October 2023 82,872
NET BOOK VALUE
At 31 October 2023 14,563
At 31 October 2022 21,157

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.10.23 31.10.22
value: £    £   
100 Ordinary 0.01 1 1

6. ULTIMATE CONTROLLING PARTY

The company is under the control of the director by her shareholding in the business. .